CDSCO cancels registration of Ethics Committee for non-compliance with clinical trial rules

The Central Drugs Standard Control Organisation (CDSCO), India’s national drug regulatory authority has cancelled the registration of a Gujrat based Ethics Committee, for non-compliance with the New Drugs and Clinical Trials Rules, 2019. The action takes the total number of Ethics Committees whose registrations have been cancelled by the regulator to eight. Ethics Committees review and approve clinical trial protocols and oversee trials to protect participants’ rights, safety and well-being.